<code id='4B199EBDF6'></code><style id='4B199EBDF6'></style>
    • <acronym id='4B199EBDF6'></acronym>
      <center id='4B199EBDF6'><center id='4B199EBDF6'><tfoot id='4B199EBDF6'></tfoot></center><abbr id='4B199EBDF6'><dir id='4B199EBDF6'><tfoot id='4B199EBDF6'></tfoot><noframes id='4B199EBDF6'>

    • <optgroup id='4B199EBDF6'><strike id='4B199EBDF6'><sup id='4B199EBDF6'></sup></strike><code id='4B199EBDF6'></code></optgroup>
        1. <b id='4B199EBDF6'><label id='4B199EBDF6'><select id='4B199EBDF6'><dt id='4B199EBDF6'><span id='4B199EBDF6'></span></dt></select></label></b><u id='4B199EBDF6'></u>
          <i id='4B199EBDF6'><strike id='4B199EBDF6'><tt id='4B199EBDF6'><pre id='4B199EBDF6'></pre></tt></strike></i>

          Home / explore / hotspot

          hotspot


          hotspot

          author:entertainment    Page View:226
          Franklin faces
          Adobe

          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

          advertisement

          Arch declined to comment on the new fundraising.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In